fasudil has been researched along with Astrocytosis in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fasudil (20μM) significantly reduces the expression of GFAP in A172 cells and in spinal cord dorsal column." | 1.40 | Fasudil reduces GFAP expression after hypoxic injury. ( Agrawal, SK; Barnes, R; Kesherwani, V; Tarang, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kesherwani, V | 1 |
| Tarang, S | 1 |
| Barnes, R | 1 |
| Agrawal, SK | 1 |
1 other study available for fasudil and Astrocytosis
| Article | Year |
|---|---|
Fasudil reduces GFAP expression after hypoxic injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Astrocytes; Cell Hypoxia; Cell Line, Tumor; | 2014 |